Description
瑞士宝盛投资咨询部大中华市场（香港）主管周淑玲女士 (Pat Chau) 与香港区研究部主管邓启志(Richard Tang)一同讲解瑞士宝盛对下半年的投资展望。股票仍有进一步上升的潜力，但经过去年一年的强劲表现之后，未来几个月的回报或趋于平淡。就行业而言，医疗保健仍然是我们看好的防御性行业。此外，我们认为部分小市值股和在危机期间适时做出调整的公司最有望从持续的经济复苏中受益。
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast